+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Conatus Pharmaceuticals - logo

Conatus Pharmaceuticals is a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease. Its lead compound, emricasan, is a first-in-class, orally active pan-caspase protease inhibitor designed to reduce the activity of human caspases. In December 2016, Conatus announced an exclusive option, collaboration and license agreement with Novartis for the global development and commercialization of emricasan. The company was founded in 2005 and is headquartered in San Diego, California.

Primary Sclerosing Cholangitis Market By Treatment Type, By Drug Class (Ursodeoxycholic Acid, Immunosuppressants, Antibiotics), Distribution Channel, and by Region - Global Forecast to 2023-2033 - Product Thumbnail Image

Primary Sclerosing Cholangitis Market By Treatment Type, By Drug Class (Ursodeoxycholic Acid, Immunosuppressants, Antibiotics), Distribution Channel, and by Region - Global Forecast to 2023-2033

  • Report
  • February 2023
  • 200 Pages
  • Global
From
2019 Autoimmune Hepatitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Autoimmune Hepatitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 51 Pages
  • Global
From
Non-alcoholic Steatohepatitis Biomarkers Market Analysis by Type (Hepatic Fibrosis, Serum, Oxidative Stress, Apoptosis), by End User (Hospitals, Pharmaceutical & CRO Industry, Diagnostic Labs), and by Region - Forecast to 2029 - Product Thumbnail Image

Non-alcoholic Steatohepatitis Biomarkers Market Analysis by Type (Hepatic Fibrosis, Serum, Oxidative Stress, Apoptosis), by End User (Hospitals, Pharmaceutical & CRO Industry, Diagnostic Labs), and by Region - Forecast to 2029

  • Report
  • April 2022
  • 145 Pages
  • Global
From
Non-alcoholic Steatohepatitis (NASH): Global Strategic Business Report - Product Thumbnail Image

Non-alcoholic Steatohepatitis (NASH): Global Strategic Business Report

  • Report
  • September 2023
  • 179 Pages
  • Global
From
Primary Sclerosing Cholangitis Market, by Drug and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 - Product Thumbnail Image

Primary Sclerosing Cholangitis Market, by Drug and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • Report
  • November 2022
  • 134 Pages
  • Global
From
Nonalcoholic Steatohepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 - Product Thumbnail Image

Nonalcoholic Steatohepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

  • Report
  • June 2022
  • 150 Pages
  • Global
From
Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Global Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2023 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) Global Market Report 2023

  • Report
  • May 2023
  • 250 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Treatment Global Market Report 2023 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Treatment Global Market Report 2023

  • Report
  • March 2023
  • 200 Pages
  • Global
From
Type 1 Diabetes - Pipeline Insight, 2022 - Product Thumbnail Image

Type 1 Diabetes - Pipeline Insight, 2022

  • Drug Pipelines
  • July 2022
  • 220 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Market Analysis by Disease Cause, by Drug Type, by End-User and Segment Forecast to 2027 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Market Analysis by Disease Cause, by Drug Type, by End-User and Segment Forecast to 2027

  • Report
  • August 2020
  • 225 Pages
  • Global
From
Emricasan (Conatus/Novartis) Drug Overview 2019 - Product Thumbnail Image

Emricasan (Conatus/Novartis) Drug Overview 2019

  • Report
  • July 2019
  • 12 Pages
  • Global
Polycystic Kidney Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Polycystic Kidney Disease Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 98 Pages
  • Global
From
2019 Fatty Liver Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Fatty Liver Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 356 Pages
  • Global
From
2019 Steatohepatitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Steatohepatitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 389 Pages
  • Global
From
2019 Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Non Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 344 Pages
  • Global
From
Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2020 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Liver Failure Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Liver Failure Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2022
  • 92 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2022
  • 95 Pages
  • Global
From
Fatty Liver Disease Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Fatty Liver Disease Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Market Participants, Regions, Technology, Application

  • Report
  • May 2022
  • 102 Pages
  • Global
From
Loading Indicator